<DOC>
	<DOC>NCT01533844</DOC>
	<brief_summary>The objective of this multi-center, prospective observational study is to determine the feasibility of a potential interventional study with fidaxomicin. The incidence and clinical aspects of Clostridium difficile infection (CDI) in neonates will be determined, and it will be assessed whether a subgroup can be identified where treatment with fidaxomicin therapy might improve outcome.</brief_summary>
	<brief_title>To Determine the Feasibility of a Fidaxomicin Study in Neonates and to Assess C. Difficile (Clostridium Difficile) Involvement in the Pathogenesis</brief_title>
	<detailed_description />
	<criteria>Subject is suffering from diarrhea or other signs or symptoms consistent with CDAD (as described in section 5.2.3) Presence of either toxin A or B (or both) of C. difficile in the stool within 24 hours prior to enrollment using the C. difficile Quik Chek CompleteÂ® diagnostic test, provided by the sponsor Subject will be excluded from participation if any of the following apply: Preterm neonates Negative C. difficile toxin test</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>27 Days</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>CDAD</keyword>
	<keyword>Neonates</keyword>
	<keyword>Clostridium difficile</keyword>
</DOC>